1. Home
  2. FRPH vs SLDB Comparison

FRPH vs SLDB Comparison

Compare FRPH & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FRP Holdings Inc.

FRPH

FRP Holdings Inc.

HOLD

Current Price

$23.86

Market Cap

435.3M

Sector

Finance

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$6.86

Market Cap

444.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FRPH
SLDB
Founded
1986
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
435.3M
444.9M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FRPH
SLDB
Price
$23.86
$6.86
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$14.70
AVG Volume (30 Days)
60.8K
950.8K
Earning Date
03-04-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.24
N/A
Revenue
$33,049,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$97.90
N/A
Revenue Growth
5.21
N/A
52 Week Low
$21.68
$2.41
52 Week High
$31.99
$7.37

Technical Indicators

Market Signals
Indicator
FRPH
SLDB
Relative Strength Index (RSI) 54.66 69.49
Support Level $23.42 $5.26
Resistance Level $24.62 $5.96
Average True Range (ATR) 0.53 0.41
MACD 0.07 0.10
Stochastic Oscillator 61.14 96.25

Price Performance

Historical Comparison
FRPH
SLDB

About FRPH FRP Holdings Inc.

FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: